老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AbCellera Biologics

3.34
-0.0700-2.05%
成交量：18.11万
成交额：60.27万
市值：9.97亿
市盈率：-5.88
高：3.35
开：3.35
低：3.32
收：3.41
数据加载中...
总览公司新闻公告
2021/04/01

重要事件披露

8-K - Current report
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/29

重要事件披露

8-K - Current report
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/28

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/03

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/20

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933